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Background:  
Respiratory viral disease is a serious public health problem globally with considerable social and economic impacts. Respiratory viruses cause respiratory disease that 
ranges from mild to severe pneumonia, contributing for morbidity and mortality throughout the world. The etiological diagnosis based on clinical presentation is very difficult 
due to the similarity of clinical presentation of respiratory viral infections. In order to have a more complete knowledge on the viral etiology of influenza like illness in 
Portugal, a search for viral agents (including influenza) was done in the framework of the National Influenza Surveillance System, from season 2010/2011 to 2012/2013.  
Material and Methods:   
During the 3 winter seasons cases of influenza like illness (ILI) according to the EU case definition were notified by the sentinel and non-sentinel networks. For each studied 
case a nasopharyngeal swab collected in the first seven days after symptoms onset was received in the National Influenza Reference Laboratory. A multiplex real time PCR 
for influenza detection was performed for all the samples. All the influenza A were subtyped using the Prodesse Proflu+ (GeneProbe, Inc.), and influenza B lineage was 
determined using the WHO recommended protocol. The other respiratory viruses: human rhinovirus (hRV), respiratory sincicial virus A and B (RSV A, RSVB), parainfluenza 
virus 1, 2 and 3 (PIV1, 2, 3), adenovirus (AdV) and metapneumovirus (hMPV) were detected by a multiplex real time PCR, allowing detection of multiple infections. From the 
first winter, 2010/2011, a random selection of 378 ILI cases (taking into account the time and age distribution of cases representing 37.2% of the reported cases) was 
analyzed. In the following seasons 2011/2012 and 2012/2013 all samples were tested for influenza and other respiratory viruses, corresponding to 678 cases and 1256 
cases, respectively. For the 2012-13 season the odds ratio (OR) of being positive for specific respiratory virus for each sign/symptom was calculated. 
Results:  
A total of 2318 samples were 
analyzed for the 3 seasons. In 
each season the causal agent was 
identified in 68%, 52% and 61% of 
the samples, respectively (Figure 
1). 
The flu virus was the most 
frequently detected agent 
accounting for 53.4%, 37.5% and 
43.0% of the cases analyzed 
(Figure 1). In co-circulation with flu, 
hRV and RSV were detected in the 
highest percentage of cases after 
influenza viruses (Figure 1 and 2). 
hRV was detected throughout the 
winter in 8-9% of ILI cases, while 
the RSV circulated simultaneously 
with the influenza virus and its 
detection ranged from 2 to 5% of 
ILI cases (Figure 1 and 2). The PIV, 
hMPV and AdV virus were detected 
sporadically. There were cases of 
mixed infections of 2 or more 
viruses (representing 1-2%), mostly 
associated with the influenza virus. 
In the three seasons the highest 
percentage of positive cases was 
detected in children between 0-4 
years (Figure 3). 
Conclusions:  
The detection of other respiratory viruses enabled the laboratory diagnosis of more than 50 % of ILI cases. The other respiratory 
viruses accounted for 10-15% of the ILI positives, with greater prevalence for hRV and RSV. Influenza and RSV co-circulated in the 3 
winter as described before (Zambon et al., 2001). For the majority of the investigated respiratory virus the presence of one or two 
signs or symptom was associated to be positive for that virus. These included fever/ cough (Influenza), sore throat (hRV and RSV), 
shortness of breath (RSV) and chills (PIV, hMPV and AdV virus). The absence of fever and chills was associated to the detection of 
the hRV. 
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Figure 1 – Number and percentage of flu and 
respiratory viruses detected in 2010/2011, 
2011/2012 and 2012/2013 winter seasons. 
Figure 2 – Detection of hRV, RSV and Flu viruses per 
week in 2010/2011, 2011/2012 and 2012/2013 winter 
seasons. 
Figure 3 – Percentage of positive cases and 
number of detected flu and other respiratory virus 
by age group in 2010/2011, 2011/2012 and 
2012/2013 winter seasons. 
Table I – Association between the presence of signs and symptoms and a case of infection by flu and other respiratory viruses. 
Odds 
ratio
IC95%
Odds 
ratio
IC95%
Odds 
ratio
IC95%
Odds 
ratio
IC95%
Odds 
ratio
IC95%
Odds 
ratio
IC95%
Sudden Onset 1,14  (0,82 - 1,58) 1,36  (0,9 - 2,04) 0,74  (0,52 - 1,04) 1,28  (0,65 - 2,55) 1,71  (0,94 - 3,11) 0,92  (0,77 - 1,1)
Fever 3,13  (1,89 - 5,19) 2,82  (1,4 - 5,66) 2,24  (1,23 - 4,07) 0,69  (0,32 - 1,5) 0,45  (0,26 - 0,79) 1,45  (0,5 - 4,22)
Malaise 1,05  (0,68 - 1,64) 1,80  (0,99 - 3,28) 0,70  (0,45 - 1,09) 1,06  (0,45 - 2,51) 0,63  (0,35 - 1,13) 1,43  (0,43 - 4,81)
Headache 1,30  (0,97 - 1,75) 1,25  (0,87 - 1,79) 1,17  (0,84 - 1,64) 1,41  (0,74 - 2,69) 0,83  (0,53 - 1,3) 1,77  (0,76 - 4,1)
Myalgia 1,38  (0,93 - 2,05) 2,64  (1,47 - 4,77) 0,89  (0,6 - 1,34) 0,69  (0,35 - 1,35) 0,73  (0,43 - 1,25) 1,48  (0,51 - 4,29)
Cough 3,94  (2,52 - 6,16) 5,43  (2,36 - 12,48) 1,74  (1,05 - 2,88) 2,83  (0,88 - 9,13) 1,16  (0,6 - 2,21) 1,88  (0,72 - 4,89)
Sore throat 1,14  (0,85 - 1,53) 0,73  (0,52 - 1,02) 0,99  (0,71 - 1,38) 2,23  (1,05 - 4,72) 2,85  (1,51 - 5,39) 1,13  (0,56 - 2,28)
Chills 1,28  (0,94 - 1,74) 1,27  (0,88 - 1,84) 1,05  (0,75 - 1,48) 1,06  (0,58 - 1,95) 0,63  (0,41 - 0,99) 4,04  (1,22 - 13,35)
Shortness of breath 0,70 (0,52 - 0,94) 1,14 (0,81 - 1,59) 0,44 (0,30 - 0,65) 1,77  (1,05 - 2,98) 1,35  (0,88 - 2,09) 1,06  (0,54 - 2,10)
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n=1262In the 2012-13 season and 
considering signs and symptoms 
more associated to Influenza virus 
infection (Table I), significant 
association was found with fever 
(OR=3.13), and cough (OR=3.94). 
These results were similar if we 
consider the influenza sub-types 
A(H1)pdm09 (Fever: OR=2.82; 
Cough: OR=5.43) and B Yamagata 
lineage (Fever: OR=2.24; Cough: 
OR=1.74). Additionally, with 
A(H1)pdm09 infection was also 
associated the symptom of Myalgia 
(OR=2.64). There is a high 
probability that we are not dealing 
with a case of flu B/Yamagata 
(OR=0.44) or even flu (OR=0.70) 
whenever there is shortness of 
breath. We also found a strong 
association between sore throat 
and the hRV (OR= 2.85) and RSV 
(OR= 2.23) infections. Shortness of 
breath was also associated with 
infection by RSV (OR= 1.77). A 
negative correlation was found 
between fever and hRV infection 
(OR= 0.45). 
Chills were the only symptom 
associated with infection by other 
respiratory viruses (PIV, AdV and 
hMPV) (OR= 4.04). At the same 
time, chills indicate a low 
probability of infection by hRV 
(OR= 0.63) (TableI). 
